As part of the development process, our investigational radioligand products are evaluated in clinical trials to find new and better ways to image and treat disease. These studies are sponsored by Advanced Accelerator Applications (AAA).
Investigational products tested in clinical trials may not be approved by regulatory authorities, or they may be approved for certain indications but being tested to determine if they are useful in other conditions. Patients should discuss their potential participation in such studies with their physician. The table below lists ongoing oncology clinical trials with our investigational drugs.
Pre-Approval Access to AAA Products
As a Novartis Company, AAA is following the Novartis Position on Pre-Approval Access to Novartis Products through Novartis Managed Access Programs (MAPs).
If you need more information or want to submit a request for MAP, please visit the Novartis Managed Access Programs webpage.